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Abstract Succinate:quinone (SQR) and quinol:fumarate oxi-
doreductases (QFR) are members of the same enzyme family.
These are membrane bound enzymes anchored to the membrane
by one or two subunits that may contain two, one or no haems.
For the dihaemic enzymes the electron pathway from the £avin
at the catalytic centre to the quinones remains to be established.
Taking into account that the two haems are located on opposite
sites of the membrane, and the possible presence of two quinone
binding sites, also located on opposite sides of the membrane, we
re-hypothesise the presence of a Q-cycle type mechanism in
these enzymes. Such a mechanism can explain an active func-
tional role for two haems and two quinone binding sites, allow-
ing SQR to conserve energy. With this testable hypothesis we
intend to challenge the discussion and drive further experimen-
tation to unravel the functional mechanism of SQRs and QFRs.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Succinate:quinone (SQR) and quinol:fumarate oxidoreduc-
tases (QFR) are closely related enzymes. Recently, they have
been the topic of a special review issue [1] and the crystallo-
graphic structures from Escherichia coli and Wolinella succi-
nogenes QFRs have already been elucidated [2,3]. A £avopro-
tein, an iron^sulphur protein facing the cytoplasm, and a
membrane domain constitute these enzymes (Fig. 1). The £a-
voprotein contains the FAD site where the catalytic reaction
with succinate and fumarate occurs. A [2Fe^2S]2þ=1þ, a [3Fe^
4S]1þ=0 (or a [4Fe^4S]2þ=1þ in some cases) and a [4Fe^4S]2þ=1þ
cluster are present in the iron^sulphur protein and arranged in
a wire-like manner, allowing the electron transfer from the
£avin to the membrane domain. This domain can be consti-
tuted by one or two subunits composed by transmembrane or
possibly monotopic helices [4]. In the former case the trans-
membrane domain can contain two, one or no haems [5]. The
absence of haems is also observed in the enzymes having
monotopic helices [4].
2. Presence of two haems
The crystallographic structure of W. succinogenes QFR
shows the presence of two B type haems, close to the opposite
sides of the membrane and with both planes almost perpen-
dicular to the membrane surface [3]. Due to their position in
relation to the peripheral domain the haems were named
proximal (bp) and distal (bd) (Fig. 1). The presence of two
B type haems has also been observed in the SQR from Ba-
cillus subtilis [6] and Rhodothermus marinus [7] and in the
QFR from Desulfovibrio gigas [8] ; on the bases of their amino
acid sequences the presence of two haems is anticipated in the
SQRs from Bacillus halodurans, Paenibacillus macerans, Chla-
mydia muridarum, Chlamydophila pneumoniae, Deinococcus ra-
diodurans, Mycobacterium tuberculosis, Natronomonas pharao-
nis and Halobacterium sp, and in the QFRs from Aeropyrum
pernix, Archaeoglobus fulgidus, Campylobacter jejuni, Helico-
bacter pylori, Thermoplasma acidophilum and Thermoplasma
volcanium [4].
The haems present di¡erent absorbance and redox proper-
ties [5,7], one having a high reduction potential (bH) and the
other a low reduction potential (bL). Based on site-directed
mutants it was possible to assign bL as the distal haem and bH
as the proximal haem [9^11].
3. Presence of two quinone binding sites
The number and location of quinone binding sites in SQR/
QFR are still under debate. No electron density for a quinone
was observed in the crystallographic structure of W. succino-
genes QFR [3], whereas two menaquinone molecules situated
on opposite sides of the membrane were observed in the crys-
tallographic structure of E. coli QFR [2]. Similarly to the case
of the haems, these quinone binding sites were named prox-
imal (QP) and distal (QD). Based on kinetics of inhibition by a
sec-butyl-4,6-dinitrophenol derivative two quinone binding
sites had already been proposed for the E. coli QFR and
for the bovine SQR [12]. A wealth of data using other inhib-
itors and site-directed mutants have also indicated the pres-
ence of two quinone binding sites present in the dihaemic
B. subtilis SQR [5]. Also using the same approaches a QP
site is predicted to be present in the monohaemic SQRs
from Bos taurus, E. coli, Paracoccus denitri¢cans, Ascaris
suum and Ustilago maydis [5], and a QD site in W. succino-
genes QFR [13]. Based on random mutagenesis and inhibitor
sensitivity, the presence of both QP and QD binding sites was
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proposed for the monohaemic SQR of Saccharomyces cerevi-
siae mitochondria [14].
Fig. 2 shows the amino acid sequence alignment of the
membrane subunit(s) of dihaemic SQR/QFRs and their
general secondary structure prediction. As mentioned above
the presence of a QD site in these enzymes is accepted [5,13],
while the presence of a QP site has been suggested for the
B. subtilis SQR [5]. The presence of a QP site should be
near haem bP and thus it should be situated in a region com-
prising the end of helix II, loop B and the beginning of helix
IV, or in a region including the end of helix V, loop D (Fig. 2)
and the beginning of helix VI. An extensive variability can
occur in quinone binding sites. However, the amino acids
found at these sites are mainly of two types [15] : those able
to establish hydrogen bonds with the oxygen atoms of the
quinone, and those able to perform ring staking interactions,
such as the aromatic amino acid residues. Several motifs for
quinone binding sites have been proposed [15]. One such mo-
tif is L(X)3H(X)2T (being X any amino acid) and indeed a
similar motif is present in W. succinogenes and H. pylori
QFRs ^ L(X)2H(X)2T (LeuC117 to ThrC123, W. succino-
genes, Fig. 2). This motif is present at the end of loop B
(Fig. 2), and the beginning of helix IV, which situates it close
to haem bP. In the sequence alignment in Fig. 2, in the same
place of that motif in the other enzymes there are several
aromatic amino acid residues that could be part of a quinone
binding site.
However, as for many other quinone binding proteins, con-
served motifs cannot be assigned for other SQRs. Neverthe-
less, the available data strongly raise the possibility for the
presence of two quinone binding sites in dihaemic SQRs/
QFRs.
4. The Q-cycle mechanism for SQR/FQR
Based on the previous considerations, besides the £avin and
the iron^sulphur clusters, two low-spin haems and two qui-
none binding sites are assumed to be present in dihaemic
SQRs/QFRs. In our perspective the role of all these prosthetic
groups has to be functional. A Q-cycle type mechanism [16],
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Fig. 1. Schematic representation of a SQR/QFR family member.
These enzymes are composed by two peripheral subunits, one con-
taining a £avin and the other containing a [2Fe^2S]2þ=1þ, a [3Fe^
4S]1þ=0 (or a [4Fe^4S]2þ=1þ) and a [4Fe^4S]2þ=1þ cluster and one
transmembrane domain.
                                                                                                                                  
                            
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                              
                                                                                                                                           
                    
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                           
                                                                                                                                           
                            
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                          
Fig. 2. Amino acid sequence alignment (accession numbers in parentheses) of subunit C and subunits C+D from B. subtilis (CAA99546),
B. halodurans (NP_243959), P. macerans (CAA69871), C. pneumoniae AR39 (NP_445621), C. muridarum (NP_297255), D. radiodurans
(NP_294678, NP_294677), M. tuberculosis (NP_337946, NP_337945), N. pharaonis (T44959, T44960), A. fulgidus (NP_069518, NP_069517),
T. volcanium (NP_111264, NP_111263), H. pylori (Q9ZMN9), W. succinogenes (P17413). Alignments were performed using Clustal W Version
1.6 [24] and manually adjusted.
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working inversely to that proposed for the bc1 complexes, is a
plausible model for a functional role of all the prosthetic
groups present in dihaemic SQR/QFR. Such a model was
previously discussed [5]. Here we present a more detailed hy-
pothesis for such a Q-cycle mechanism, using the more exten-
sive experimental data gathered up to date. Fig. 3 shows
schematically such a mechanism in dihaemic SQRs. We pos-
tulate that the two quinone binding sites have di¡erent a⁄n-
ities for menaquinone and menaquinol, similarly to the situa-
tion in the bc1 complex (e.g. [17]). QP has preference for
menaquinone, while QD has a higher a⁄nity for menaquinol,
being also able to stabilise the semimenaquinone form. We
propose the presence of two electron pathways: one from
the FAD through the iron^sulphur clusters to the QP site
and the other from the QD site through the haems bL and
bH to the QP site. At the beginning of a cycle QP is occupied
with a menaquinone molecule, while in QD a menaquinol
molecule is present. The presence of succinate starts the reac-
tion by giving two electrons to the £avin and producing fu-
marate and two Hþ. One electron stays in the £avin and the
other passes through the iron^sulphur clusters to the mena-
quinone bound at the QP site, which becomes totally reduced
by haem bH (Fig. 3A). By this process a molecule of mena-
quinol is formed with the concomitant consumption of two
Hþ. Once haem bH is oxidised, it is rereduced by haem bL,
which in its turn is rereduced by the menaquinol molecule at
QD (Fig. 3A). This menaquinol is now in the form of semi-
menaquinone and two protons were produced; at the same
time the menaquinol present in QP exchanges with the mena-
quinone pool and a new menaquinone molecule is now at this
site (Fig. 3B). Due to their reduction potentials the second
electron that stayed at the £avin should be by now at the
[3Fe^4S] centre (Fig. 3B). The cycle is only complete when
this electron and another from haem bH reduce the new me-
naquinone molecule at QP to menaquinol with the consump-
tion of two more protons (Fig. 3C). The rereduction of this
haem occurs by the semimenaquinone at QD in the same
manner as described for the ¢rst half cycle, i.e. through
haem bL and at the same time the menaquinol molecule at
QP exchanges again with the menaquinone pool (Fig. 3C).
After the exchange of the menaquinone at QD by a menaqui-
nol molecule the enzyme is ready for a new cycle. The mech-
anism for quinol fumarate oxidoreductases should be exactly
the inverse.
To summarise, we propose that in a turnover situation, as
the one depicted in Fig. 3, the prosthetic groups are always
reduced, being the menaquinone at QP almost simultaneously
reduced by the [3Fe^4S] centre and haem bH.
This Q-cycle mechanism where a semimenaquinone is sta-
bilised at QD is compatible with the B. subtilis SQR behaviour
with HQNO, an inhibitor analogous to semimenaquinone.
The presence of HQNO in this enzyme a¡ects the spectral
and redox properties of haem bL [18]. Also the possibility
that haem bH is reduced by haem bL explains the observation
that in the isolated B. subtilis SQR membrane anchor the
haem bH can be reduced by succinate in the presence of cata-
lytic amounts of puri¢ed SQR and DMN (a low reduction
potential menaquinone analogue), but not, in the same con-
ditions, in a membrane anchor domain lacking haem bL [5].
5. Proton translocation balance of the Q-cycle mechanism
Each cycle of the proposed mechanism involves four elec-
trons and eight Hþ. Two electrons come from the oxidation of
succinate to fumarate and the two others from the oxidation
of the menaquinol molecule at the QD site to menaquinone.
These four electrons reduce two molecules of menaquinone at
the QP site to menaquinol. From the eight Hþ involved in the
reactions two are produced by the oxidation of succinate and
two other by the oxidation of the menaquinol molecule at the
QD site. The other four are consumed by the reduction of the
two molecules of menaquinone at the QP site. If the protons
involved in the reduction and oxidation of the quinones and
quinols are taken up and released to the respective sides of the
membrane, i.e. if at QD protons are released to the periplasm
and if at QP protons are taken up from the cytoplasm, there
would be a net proton translocation by SQRs according to the
following equation,
succinateþ 2MQin þ 4Hþin þMQH2out
3fumarate þ 2Hþin þ 2MQH2in þMQout þ 2Hþout
or,
succinateþ 2MQin þ 2Hþin þMQH2out
3fumarate þ 2MQH2in þMQout þ 2Hþout ð1Þ
In B. subtilis it was shown that SQR activity is higher in the
presence of a membrane potential, since succinate:oxygen oxi-
doreductase activity is lower in membranes than in intact cells
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Fig. 3. Schematic representation of the Q-cycle mechanism model
for dihaemic SQRs/QFRs. See text for details.
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[19]. Also Schirawski and Unden [20] have observed in cells
from B. subtilis and related bacteria that succinate:oxygen
oxidoreductase activity is suppressed upon addition of iono-
phores. This was interpreted as the need of a membrane po-
tential to promote the thermodynamically unfavourable elec-
tron transfer from succinate to menaquinone. However,
recently Azarkina and Konstantinov [21] observed that in B.
subtilis the loss of activity by suppression of the membrane
potential was not exclusive of succinate:menaquinone oxido-
reductase, but rather a general e¡ect of several dehydrogen-
ases dealing with menaquinone. With their results the authors
proposed a regulatory common e¡ect of the membrane poten-
tial on those enzymes in B. subtilis.
In the case of QFRs a decrease of the membrane potential
would be observed. Recently it was shown in a reconstituted
system that W. succinogenes QFR is electrogenically neutral
[22]. If in the quinol:fumarate oxidoreduction (inverse to that
described above) the protons involved in the oxidation of the
menaquinol molecule at the QP site were not released to the
cytoplasm, but instead could go through some proton channel
close to the QD site where they could be used in the reduction
of the menaquinone molecule at this site, Eq. 1 would be
written in the following manner with a vpH=0.
succinate þ 2MQin þ 2Hþin þ 2Hþch þMQH2out3
fumarate þ 2Hþin þ 2MQH2in þMQout þ 2Hþch
or,
succinate þ 2MQin þMQH2out3
fumarate þ 2MQH2in þMQout ð2Þ
The existence of such a channel would allow the QFR not to
decrease the proton gradient. Recently, the possible existence
of a proton channel in the membrane subunit of W. succino-
genes was proposed, in the context of a completely di¡erent
hypothesis and based on the crystallographic structure [23]. A
glutamate residue (E180 W. succinogenes numbering) was pro-
posed to be part of such a channel.
6. Advantages of the Q-cycle
The presence of a Q-cycle type mechanism in dihaemic
SQRs provides a functional role to all prosthetic groups of
these enzymes and allows the cells to possess another energy
conserving respiratory complex. Nature tends to optimisation
and thus it would be more advantageous to have an enzyme,
involved in the energetic metabolism, with such a functional
mechanism that allows energy conservation, than with an en-
ergy dissipating mechanism. As discussed previously a Q-cycle
type mechanism would result in the net translocation of 4Hþ
in SQRs, while a mechanism involving only one quinone bind-
ing site near haem bL would contribute to the dissipation of
the ion motive force by 4Hþ. This hypothesis is testable ex-
perimentally and allows designing new experiments to unravel
the functional mechanism of these enzymes.
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